Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19514668 | 0.87 | KIF11 (0.53) | KIF11MAPK1TSHRALDH1A1 | |
| SCHEMBL19514691 | 0.83 | KIF11 (0.58) | KIF11 | |
| SCHEMBL977258 | 0.83 | KIF11 (0.58) | KIF11 | |
| SCHEMBL1126001 | 0.76 | CA1 (0.41) | KIF11MAPK1TSHRALDH1A1 | |
| SCHEMBL5507220 | 0.74 | KIF11 (0.44) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL114237 | 0.74 | KIF11 (0.50) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL22892484 | 0.74 | KIF11 (0.44) | KIF11MAPK1KCNN4ALDH1A1ALOX15 | |
| SCHEMBL7715769 | 0.73 | KIF11 (0.48) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL34009 | 0.73 | KIF11 (0.48) | KIF11MAPK1KCNN4TSHRALDH1A1 | |
| SCHEMBL23499891 | 0.71 | NFE2L2 (0.40) | KIF11TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210189392-A1 | S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS | ALIGOS THERAPEUTICS, INC. | 2021-06-24 | — | — | US | claimed |
| CN-104725628-B | A kind of single functionalization branched polyethylene glycol, preparation method and its bio-related substance containing degradable group | 厦门赛诺邦格生物科技股份有限公司 | 2018-04-17 | — | — | CN | claimed |
| CN-104530417-B | A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof | 厦门赛诺邦格生物科技股份有限公司 | 2017-09-08 | — | — | CN | claimed |
| CN-104530415-B | A kind of different functionalization Y types polyethyleneglycol derivative, preparation method and its bio-related substance | 厦门赛诺邦格生物科技股份有限公司 | 2017-09-01 | — | — | CN | claimed |
| CN-104109235-B | A kind of single functionalized poly (ethylene glycol), preparation method and its bio-related substance with nitrogen-atoms branch centers | 厦门赛诺邦格生物科技股份有限公司 | 2017-07-18 | — | — | CN | claimed |
| CN-104725628-A | Single functional branched polyethylene glycol containing degradable radical, preparation method and biorelevant substance of single functional branched polyethylene glycol | XIAMEN SINOPEG BIOTECH CO LTD | 2015-06-24 | — | — | CN | claimed |
| CN-104530415-A | Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof | XIAMEN SINOPEG BIOTECH INC | 2015-04-22 | — | — | CN | claimed |
| CN-104530417-A | Multifunctional H-type polyethylene glycol derivative and preparation method thereof | XIAMEN SINOPEG BIOTECH INC | 2015-04-22 | — | — | CN | claimed |
| CN-104109235-A | Mono-functionalized polyethylene glycol with nitrogen atom branched center and its preparation method and biologically-relevant matter | XIAMEN SINOPEG BIOTECH CO LTD | 2014-10-22 | — | — | CN | claimed |
| US-20020190759-A1 | Electrochemically accelerated self-assembly of molecular devices | NATIONAL SCIENCE FOUNDATION | 2002-12-19 | — | — | US | claimed |
| US-12611462-B2 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | CITY OF HOPE (US) | 2026-04-28 | — | — | US | disclosed |
| US-12252511-B2 | Process for the preparation of cyclic depsipeptides | ONKURE, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| US-20240116989-A1 | PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES | ONKURE, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| US-11739123-B2 | Process for the preparation of cyclic depsipeptides | ONKURE, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11629171-B2 | Beta-hairpin peptidomimetics | SPEXIS AG (CH) | 2023-04-18 | — | — | US | disclosed |
| WO-1995001990-A1 | HEMOREGULATORY PENTA- OR HEXAPEPTIDES | NYCOMED PHARMA A.S (NO) | 1995-01-19 | — | — | WO | disclosed |
| CN-1091138-A | Vaccine | DEAKIN RES LTD (AU) | 1994-08-24 | — | — | CN | disclosed |
| WO-1994005311-A1 | RETRO-, INVERSO-, AND RETRO-INVERSO SYNTHETIC PEPTIDE ANALOGUES | DEAKIN RESEARCH LIMITED (AU) | 1994-03-17 | — | — | WO | disclosed |
| WO-1991012021-A2 | THERAPEUTIC AGENTS, AND INTERMEDIATES FOR THE SYNTHESIS THEREOF | OXFORD VIROLOGY PLC (GB) | 1991-08-22 | — | — | WO | disclosed |
| US-4346187-A | AND ORGANIC BROMINE COMPOUND | BORG-WARNER CHEMICALS, INC. (US) | 1982-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739123-B2 | Process for the preparation of cyclic depsipeptides | VIP, LPXN, NGLY1 | KIF11 2181/4885MAPK1 1658/4885KCNN4 3425/4885 |
| US-12611462-B2 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | STAT3, NSUN2, STAT1 | KIF11 4625/4885MAPK1 1692/4885KCNN4 3119/4885 |
| US-20240116989-A1 | PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES | VIP, LPXN, NGLY1 | KIF11 2181/4885MAPK1 1658/4885KCNN4 3425/4885 |
| US-11629171-B2 | Beta-hairpin peptidomimetics | POLL, POLQ, HBZ | KIF11 2142/4885MAPK1 2245/4885KCNN4 3057/4885 |
| US-12252511-B2 | Process for the preparation of cyclic depsipeptides | VIP, LPXN, NGLY1 | KIF11 2181/4885MAPK1 1658/4885KCNN4 3425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.